100 results
8-K
EX-99.1
SCPH
scPharmaceuticals Inc.
10 Jan 25
Results of Operations and Financial Condition
8:01am
) – scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient … diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information
8-K
EX-99.1
SCPH
scPharmaceuticals Inc.
13 Nov 24
Received approval of label expansion to include New York Heart Association (NYHA) Class IV Patients
4:40pm
committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced financial results for the third quarter ended … diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information
8-K
EX-99.1
SCPH
scPharmaceuticals Inc.
14 Aug 24
Completed financing that extends our cash runway through expected profitability
4:01pm
to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced financial results for the second quarter … this week, we announced what we believe to be a transformational financing with leading healthcare-focused institutional investors which, based on our
8-K
EX-1.1
klzfn8 tbfa0inga
13 Aug 24
Other Events
8:58am
424B5
98v5ukgt29h lrfhl94z
13 Aug 24
Prospectus supplement for primary offering
8:03am
424B5
6w2 wtn219ic
12 Aug 24
Prospectus supplement for primary offering
6:48am
8-K
EX-10.1
2kkccglng7t7 71
12 Aug 24
Entry into a Material Definitive Agreement
6:08am
8-K
EX-10.2
m85xdleq5xggsph1eez
12 Aug 24
Entry into a Material Definitive Agreement
6:08am
8-K
EX-99.1
0gnqvy91714
14 May 24
Results of Operations and Financial Condition
4:07pm
PRE 14A
mb9lsa6zkdbt9w26g
12 Apr 24
Preliminary proxy
4:14pm
424B5
yzbiido
22 Mar 24
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
cj7fbum2k 4ifkw
13 Mar 24
Generated full-year net FUROSCIX® revenue of $13.6 million, at the upper end of the range provided in January
4:08pm
8-K
EX-99.1
20ivvlj nhu
4 Jan 24
Gross-to-net (GTN) discount of approximately 18% from launch through the end of Q4
5:30pm